Essential blood work before starting tirzepatide Getting baseline labs before your first injection is not optional
All gastrointestinal adverse events (GI AEs) were mild, except for one participant who reported two moderate events (nausea and vomiting) and discontinued treatment after the third administration
doi: 10.1002/epd2.20069 [PubMed] 38117319 Rossetti AO, Claassen J, Gaspard N
Approximately five of the original 19 peptides are expected to remain on the restricted list likely those with more limited safety profiles, higher misuse potential, or closer proximity to existing FDA-approved drug categories
These typically include: A complete bariatric multivitamin and mineral supplement formulated to meet the higher micronutrient requirements of post-bariatric patients
After that, our maintenance injections are administered every one to three months for individuals with normal absorption